带状疱疹 (HZ) 是一种由水痘带状疱疹病毒 (VZV) 重新激活引起的疼痛性水疱性皮疹，可能导致潜在的使人衰弱的并发症。一般人群中带状疱疹的终生风险估计为 20%-30%，其中老年人和免疫功能低下人群的风险增加。预防带状疱疹及其并发症的最有效策略是接种疫苗。带状疱疹疫苗有带状疱疹活疫苗和重组带状疱疹疫苗两种类型，已获批使用。本指南为成人带状疱疹疫苗接种提供了建议和建议，旨在减轻带状疱疹及其并发症的疾病负担。它旨在作为一线医疗保健提供者的指南，但在评估风险并向个人提供建议时不会取代临床判断。成人免疫实践工作组由台湾传染病学会（IDST）任命，并在充分查阅文献后，使用推荐、评估、发展和评价（GRADE）系统的分级起草建议。这些建议经过专家评审小组在一系列共识会议上进行审查和修订，并得到 IDST、台湾家庭医学协会、台湾皮肤病学会、台湾肿瘤学会、台湾血液与骨髓移植学会、移植学会的认可台湾爱滋病学会、台湾风湿病专科学校。本指南描述了带状疱疹的流行病学，并为具有不同风险水平、不同既往水痘带状疱疹病毒感染史以及既往水痘或带状疱疹疫苗接种史的成年人提供带状疱疹疫苗接种建议。版权所有 © 2024。由 Elsevier B.V. 出版。

Herpes zoster (HZ) is a painful, vesicular, cutaneous eruption from reactivation of varicella zoster virus (VZV), which can lead to potentially debilitating complications. The lifetime risk of HZ is estimated to be 20%-30% in the general population, with an increased risk in the elderly and immunocompromised populations. The most effective strategy to prevent HZ and its complications is by vaccination. Two types of HZ vaccines, zoster vaccine live and recombinant zoster vaccine, have been approved for use. This guidance offers recommendations and suggestions for HZ vaccination in adults, aiming to reduce the disease burden of HZ and its complications. It is intended as a guide to first-line healthcare providers, but does not supersede clinical judgement when assessing risk and providing recommendations to individuals. The Working Group on Adult Immunization Practice was appointed by the Infectious Diseases Society of Taiwan (IDST) and recommendations were drafted after a full literature review, using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. The recommendations were reviewed and revised by expert review panels during a series of consensus meetings and endorsed by the IDST, Taiwan Association of Family Medicine, the Taiwanese Dermatological Association, the Taiwan Oncology Society, the Taiwan Society of Blood and Marrow Transplantation, the Transplantation Society of Taiwan, the Taiwan AIDS Society, and the Taiwan College of Rheumatology. This guidance describes the epidemiology of HZ and provides recommendations for HZ vaccination in adults with varying levels of risk, differing history of previous VZV infection and past varicella or zoster vaccinations.Copyright © 2024. Published by Elsevier B.V.